Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression

被引：1
|
作者：
Marks, Leonard S. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
来源：
BJU INTERNATIONAL | 2014年 / 113卷 / 04期
关键词：
D O I：
10.1111/bju.12306
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E13 / E14
页数：2
相关论文
共 50 条
  • [21] A novel nomogram predicting the risk of positive biopsy for patients in the diagnostic gray area of prostate cancer
    Guang-Dong Hou
    Yu Zheng
    Wan-Xiang Zheng
    Ming Gao
    Lei Zhang
    Niu-Niu Hou
    Jia-Rui Yuan
    Di Wei
    Dong-En Ju
    Xin-Long Dun
    Fu-Li Wang
    Jian-Lin Yuan
    Scientific Reports, 10
  • [22] A novel nomogram predicting the risk of positive biopsy for patients in the diagnostic gray area of prostate cancer
    Hou, Guang-Dong
    Zheng, Yu
    Zheng, Wan-Xiang
    Gao, Ming
    Zhang, Lei
    Hou, Niu-Niu
    Yuan, Jia-Rui
    Wei, Di
    Ju, Dong-En
    Dun, Xin-Long
    Wang, Fu-Li
    Yuan, Jian-Lin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients
    Iremashvili, Viacheslav
    Barney, Shane L.
    Manoharan, Murugesan
    Kava, Bruce R.
    Parekh, Dipen J.
    Punnen, Sanoj
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 313 - 317
  • [24] YOUNGER AGE IS ASSOCIATED WITH DECREASED RISK OF BIOPSY PROGRESSION DURING ACTIVE SURVEILLANCE FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER
    Leapman, Michael
    Nguyen, Hao
    Cowan, Janet
    Perez, Nanette
    Shinohara, Katsuto
    Catalona, William
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E56 - E56
  • [25] CCP score and risk stratification for prostate cancer patients at biopsy
    Crawford, E. David
    Shore, Neal
    Scardino, Peter T.
    Davis, John W.
    Tward, Jonathan D.
    Harrison, Lowndes
    Moyes, Kelsey
    Fitzgerald, Lisa
    Stone, Steven
    Brawer, Michael K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [26] Is BMI a risk factor for active surveillance progression in patients with prostate cancer diagnosed by MRI-Trus fusion biopsy?
    Rayn, Kareem
    Gold, Samuel
    Hale, Graham R.
    Baiocco, Joey
    Bloom, Jonathan
    Valera, Vladimir
    Wood, Brad J.
    Turkbey, Baris
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [27] Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance
    Francisco, Ignacio F. San
    Werner, Lillian
    Regan, Meredith M.
    Garnick, Marc B.
    Bubley, Glenn
    DeWolf, William C.
    JOURNAL OF UROLOGY, 2011, 185 (02): : 471 - 476
  • [28] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [29] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [30] Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
    Salari, Keyan
    Kowitz, Jason
    Twum-Ampofo, Jeffrey
    Gusev, Andrew
    O'Shea, Aileen
    Anderson, Mark A.
    Harisinghani, Mukesh
    Kuppermann, David
    Dahl, Douglas M.
    Efstathiou, Jason A.
    Lee, Richard J.
    Blute, Michael L.
    Zietman, Anthony L.
    Feldman, Adam S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 387.e9 - 387.e16
12345